The anti-estrogenic effect of this compound was ascribed to a conformational change of the α-receptor site of the estrogen receptor containing protein, present in the tumor cell, upon binding of hydroxy-ferrocifen [44,46]. This evidence concerns the gene ESR1 and neoplasm.